These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

769 related articles for article (PubMed ID: 10674616)

  • 21. Changes in management techniques and patterns of disease recurrence over time in patients with breast carcinoma treated with breast-conserving therapy at a single institution.
    Pass H; Vicini FA; Kestin LL; Goldstein NS; Decker D; Pettinga J; Ingold J; Benitez P; Neumann K; Rebner M; Dekhne N; Martinez A
    Cancer; 2004 Aug; 101(4):713-20. PubMed ID: 15305400
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The presence of proliferative breast disease with atypia does not significantly influence outcome in early-stage invasive breast cancer treated with conservative surgery and radiation.
    Fowble B; Hanlon AL; Patchefsky A; Freedman G; Hoffman JP; Sigurdson ER; Goldstein LJ
    Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):105-15. PubMed ID: 9747827
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Retrospective analysis of 108 ductal carcinomas in situ of the breast treated by radiosurgery association].
    Fourneret P; Artignan X; De Cornulier J; Pasquier D; Panh MH; Payan R; Kolodié H; Vincent F; Fric D; Bernard P; Colona M; Bolla M
    Cancer Radiother; 2006 Dec; 10(8):550-8. PubMed ID: 16890006
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
    Di Saverio S; Catena F; Santini D; Ansaloni L; Fogacci T; Mignani S; Leone A; Gazzotti F; Gagliardi S; De Cataldis A; Taffurelli M
    Breast Cancer Res Treat; 2008 Jun; 109(3):405-16. PubMed ID: 17687650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breast-conserving treatment with or without radiotherapy in ductal carcinoma In Situ: 15-year recurrence rates and outcome after a recurrence, from the EORTC 10853 randomized phase III trial.
    Donker M; Litière S; Werutsky G; Julien JP; Fentiman IS; Agresti R; Rouanet P; de Lara CT; Bartelink H; Duez N; Rutgers EJ; Bijker N
    J Clin Oncol; 2013 Nov; 31(32):4054-9. PubMed ID: 24043739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mammographic, pathologic, and treatment-related factors associated with local recurrence in patients with early-stage breast cancer treated with breast conserving therapy.
    Kini VR; Vicini FA; Frazier R; Victor SJ; Wimbish K; Martinez AA
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):341-6. PubMed ID: 10030259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ductal carcinoma in situ. The success of breast conservation therapy: a shared experience of two single institutional nonrandomized prospective studies.
    Lagios MD; Silverstein MJ
    Surg Oncol Clin N Am; 1997 Apr; 6(2):385-92. PubMed ID: 9115503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ductal carcinoma in situ treated with breast-conserving surgery and radiotherapy: a comparison with ECOG study 5194.
    Motwani SB; Goyal S; Moran MS; Chhabra A; Haffty BG
    Cancer; 2011 Mar; 117(6):1156-62. PubMed ID: 21381008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fifteen-year results of breast-conserving surgery and definitive breast irradiation for the treatment of ductal carcinoma in situ of the breast.
    Solin LJ; Kurtz J; Fourquet A; Amalric R; Recht A; Bornstein BA; Kuske R; Taylor M; Barrett W; Fowble B; Haffty B; Schultz DJ; Yeh IT; McCormick B; McNeese M
    J Clin Oncol; 1996 Mar; 14(3):754-63. PubMed ID: 8622021
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of microcalcifications that develop at the lumpectomy site after breast-conserving therapy.
    Vora SA; Wazer DE; Homer MJ
    Radiology; 1997 Jun; 203(3):667-71. PubMed ID: 9169686
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preliminary results and evaluation of MammoSite balloon brachytherapy for partial breast irradiation for pure ductal carcinoma in situ: a phase II clinical study.
    Benitez PR; Streeter O; Vicini F; Mehta V; Quiet C; Kuske R; Hayes MK; Arthur D; Kuerer H; Freedman G; Keisch M; Dipetrillo T; Khan D; Hudes R
    Am J Surg; 2006 Oct; 192(4):427-33. PubMed ID: 16978943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of treatment efficacy, cosmesis, and toxicity using the MammoSite breast brachytherapy catheter to deliver accelerated partial-breast irradiation: the william beaumont hospital experience.
    Chao KK; Vicini FA; Wallace M; Mitchell C; Chen P; Ghilezan M; Gilbert S; Kunzman J; Benitez P; Martinez A
    Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):32-40. PubMed ID: 17467920
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long term follow-up of women with ductal carcinoma in situ treated with breast-conserving surgery: the effect of age.
    Van Zee KJ; Liberman L; Samli B; Tran KN; McCormick B; Petrek JA; Rosen PP; Borgen PI
    Cancer; 1999 Nov; 86(9):1757-67. PubMed ID: 10547549
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Defining negative margins in DCIS patients treated with breast conservation therapy: The University of Chicago experience.
    Sahoo S; Recant WM; Jaskowiak N; Tong L; Heimann R
    Breast J; 2005; 11(4):242-7. PubMed ID: 15982389
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Updates in the treatment of ductal carcinoma in situ of the breast.
    Lebeau A; Kühn T
    Curr Opin Obstet Gynecol; 2016 Feb; 28(1):49-58. PubMed ID: 26694830
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of treatment for patients with primary ductal carcinoma in situ in the breast.
    Fish EB; Chapman JA; Miller NA; Link MA; Fishell E; Wright B; McCready DR; Hiraki GY; Ross TM; Hanna WM; Lickley HL
    Ann Surg Oncol; 1998 Dec; 5(8):724-32. PubMed ID: 9869520
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of Radiotherapy With Survival in Women Treated for Ductal Carcinoma In Situ With Lumpectomy or Mastectomy.
    Giannakeas V; Sopik V; Narod SA
    JAMA Netw Open; 2018 Aug; 1(4):e181100. PubMed ID: 30646103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conservative therapy of breast cancer in Queensland.
    Burke MF; Allison R; Tripcony L
    Int J Radiat Oncol Biol Phys; 1995 Jan; 31(2):295-303. PubMed ID: 7836083
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intraductal carcinoma of the breast: pathologic features associated with local recurrence in patients treated with breast-conserving therapy.
    Goldstein NS; Kestin L; Vicini F
    Am J Surg Pathol; 2000 Aug; 24(8):1058-67. PubMed ID: 10935646
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Breast conserving therapy in breast cancer patients presenting with nipple discharge.
    Obedian E; Haffty BG
    Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):137-42. PubMed ID: 10758315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.